<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02771327</url>
  </required_header>
  <id_info>
    <org_study_id>FIBHGM-ECNC010-2010</org_study_id>
    <nct_id>NCT02771327</nct_id>
  </id_info>
  <brief_title>Use of a Pressurized Face Mask for Preventing Respiratory Complications After Chest Surgery</brief_title>
  <official_title>Phase 4, Randomized, Controlled Trial on the Efficacy as Prophylaxis of Postoperative Respiratory Complications and Safety of Continuous Positive Airways Pressure (CPAP) Applied Throughout Boussignac Mask During the Immediate Postoperative Period of Patients Undergoing Lung Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Gregorio Marañon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of efficacy and safety from 6hours of 7 cmH2O CPAP after weaning in patients
      undergoing lung resection, on the prevention of atelectasis / pneumonia and gas exchange
      improve.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicenter randomized clinical trial. 460 patients randomly assigned to treatment and
      control groups will be studied. The main variables are the frequency of atelectasis or
      pneumonia, defined by clinical and radiological criteria, the FiO2/PaO2 ratio, 7 and 24 h
      after weaning, and hospital stay.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of atelectasis- Pneumonia, and other postoperative complications,</measure>
    <time_frame>1 week after the surgical intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gas exchange ( Pa/FiO2)</measure>
    <time_frame>1 week after the surgical intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay comparison between arms</measure>
    <time_frame>from the surgical intervention date to hospital discharge date up to 1month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">258</enrollment>
  <condition>Lung Resection</condition>
  <arm_group>
    <arm_group_label>CPAP plus gas</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with Boussingnac valve CPAP during 6 hour, starting immediately after weaning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual treatment(ventimask plus gas)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ventimask</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP plus Gas</intervention_name>
    <arm_group_label>CPAP plus gas</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ventimask plus gas</intervention_name>
    <arm_group_label>Usual treatment(ventimask plus gas)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing thoracic surgery including resection of lung parenchyma.

          -  To have given signed consent to enter in the study.

        Exclusion Criteria:

        Weaning in the first 4h after the intervention end.

          -  Suspected bronchopleural fistula at the admission to the surgical ICU.

          -  Patients with facial problems or a history of intolerance to CPAP masks.

          -  Having significant bullous emphysema defined as the presence of more than 5 contiguous
             bullae &lt;2cm or the existence of a pulmonary bulla&gt; 2 cm or dystrophy bullosa, not in
             the area to dry and having had a previous pneumothorax.

          -  Known Obstructive Apnea Hypopnea syndrome known or some form of noninvasive
             ventilation prescribed.

          -  Immunocompromised patients, or having used an immunosuppressor drug at least one month
             prior to surgery with potential (except corticosteroids administered by inhalation)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hopsital universitario La Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HGU Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HU 12 de octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2016</study_first_posted>
  <last_update_submitted>November 17, 2016</last_update_submitted>
  <last_update_submitted_qc>November 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

